We limit data available in the Overview Report for users who do not have Powerpack
Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Target Price Range
Recommendation Rating
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 1.37 | 1.19 | 0.50 | 0.41 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 4.00 | 3.48 | 1.85 | 11.35 | — | — | — |
High Price
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,657 | 1,520 | 1,238 | 1,063 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.18 | 1.39 | 1.59 | 1.69 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,959.74 | 2,105.40 | 1,972.96 | 1,795.49 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 6.21% | 5.68% | 5.76% | 5.76% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (54.53) | (49.75) | (2.83) | (3.22) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.78%) | (2.36%) | (0.14%) | (0.18%) | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (54.53) | (49.78) | (2.85) | (3.22) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.92 | 3.07 | 2.32 | 1.69 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 235.21 | 249.74 | 229.63 | 206.35 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | (7.20) | (6.60) | (0.10) | (1.00) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.40) | (7.47) | 4.19 | 1.96 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.53) | (0.14) | (0.23) | (0.07) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.93) | (7.61) | 3.96 | 1.89 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.11) | (9.94) | (10.49) | (11.86) | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.33 | 8.43 | 8.59 | 8.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.01 | 0.01 | 0.00 | 0.01 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.03) | (0.01) | (0.02) | (0.02) | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.72 | 0.30 | (1.94) | (3.63) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.36) | (62.99) | 36.03 | 17.04 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.42) | (1.15) | (2.02) | (0.62) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.78) | (64.14) | 34.01 | 16.41 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.05 | 26.52 | 42.07 | 24.48 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.40 | 47.62 | 22.05 | 26.83 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (93.37) | (47.27) | (48.96) | (60.59) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (59.26) | (83.76) | (90.17) | (103.17) | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (12.12%) | (11.78%) | (2.17%) | (2.73%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 145.42% | 77.35% | 10.20% | 9.82% | — | — | — |
ROE
|
Analyst Commentary (Summary)
111, Inc. Sponsored ADR (YI) Latest News
17 Sep
111 Inc. received an unsolicited preliminary non-binding proposal to acquire the company. Unsolicited acquisition proposals often trigger major shifts in stock performance and strategic direction.
111, Inc. reported its unaudited financial results for the second quarter of 2026. Quarterly earnings releases frequently drive notable shifts in investor sentiment and share price movements.
111, Inc. reported its unaudited financial results for the second quarter of 2025, highlighting key metrics such as revenue growth and net income. The company continues to expand its operations and enhance its market position, reflecting a positive trajectory in its financial performance. Management expressed optimism about future growth prospects and strategic initiatives aimed at increasing shareholder value. Significant revenue growth and strategic initiatives indicate a likely positive shift in the company's market performance.
Asian equities, including the 111, Inc. Sponsored ADR (YI), experienced a significant rise in trading on Wednesday, reflecting a broader positive sentiment in the market for American Depositary Receipts (ADRs). Investors showed increased interest in Asian stocks, contributing to the upward momentum in their prices. This trend indicates a growing confidence in the performance of Asian companies listed in the US, potentially benefiting investors in these ADRs. The rise in Asian equities and ADRs suggests a moderately noticeable influence on market sentiment and performance.
4 Jun
111, Inc. reported unaudited financial results for the first quarter of 2026. Quarterly earnings releases provide performance updates that may shift near-term investor sentiment without altering long-term trajectory.
9 Apr
111, Inc. announced fourth quarter and fiscal year 2025 financial results. Quarterly and annual earnings announcements significantly affect financial performance assessments and investor sentiment.
11 Feb
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) on Wednesday, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The uptick in ADRs reflects a broader positive sentiment in the market, driven by various factors including investor interest in Asian markets and potential economic recovery signals. This trend may influence trading volumes and investor strategies related to Asian equities listed in the US. The rise in ADRs indicates a moderately noticeable influence on market sentiment and trading dynamics for 111, Inc.
111, Inc. has regained compliance with NASDAQ listing requirements after addressing previous deficiencies. The company received a notification from NASDAQ indicating that it has met the necessary criteria, allowing it to continue trading on the exchange without any further issues. This development is seen as a positive step for the company, potentially boosting investor confidence and market perception. Regaining compliance with NASDAQ requirements can positively influence investor sentiment and stabilize the company's market position.
4 Feb
Asian equities traded in the US, including 111, Inc. Sponsored ADR (YI), saw a rise in American Depositary Receipts during Wednesday trading. This uptick reflects a broader positive sentiment in the market for Asian stocks, driven by various economic factors and investor interest in the region's growth potential. The increase in Asian equities may moderately influence market sentiment and financial performance for 111, Inc.
2 Feb
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) on Monday, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The increase in ADRs reflects positive market sentiment towards Asian companies, driven by various economic factors and investor interest. This trend indicates a growing appetite for Asian equities in the US market, potentially benefiting companies like 111, Inc. as they gain visibility and investment from American investors. The rise in ADRs suggests a moderately noticeable influence on market sentiment and visibility for 111, Inc., but the overall effect is expected to be limited.
21 Jan
Asian equities traded in the US saw a significant rise in American Depositary Receipts (ADRs) on Wednesday, with 111, Inc. Sponsored ADR (YI) among those experiencing notable gains. This surge reflects a broader trend in the market, driven by positive investor sentiment and favorable economic indicators in the region. The increase in ADRs indicates growing interest in Asian companies from US investors, potentially enhancing liquidity and market presence for these firms. The rise in ADRs suggests a moderately noticeable influence on market sentiment and investor interest in 111, Inc., but the overall effect is expected to be balanced by other market factors.
13 Jan
111, Inc. Sponsored ADR (YI) is highlighted as a top penny stock to watch in January 2026 due to its recent performance and potential growth opportunities in the market. Analysts suggest that the company's strategic initiatives and market positioning could lead to increased investor interest and stock price appreciation. The focus on innovative solutions and expansion into new markets is expected to enhance its competitive edge, making it a noteworthy option for investors looking at penny stocks this month. Strategic initiatives and market positioning are likely to significantly impact future performance and investor sentiment.
23 Dec
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) on Tuesday, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The uptick in ADRs reflects growing investor interest in Asian markets, driven by positive economic indicators and market sentiment. This trend may signal a shift in investment strategies as investors look for opportunities in emerging markets. The rise in ADRs indicates a moderately noticeable influence on market sentiment and potential interest in 111, Inc.'s operations.
17 Dec
111, Inc. reported its unaudited financial results for the third quarter of 2025, highlighting key metrics such as revenue, net income, and operational performance. The company showed growth in various segments, reflecting its strategic initiatives and market positioning. Management provided insights into future expectations and ongoing projects aimed at enhancing shareholder value. The financial results indicate moderate growth and operational performance, which may influence investor sentiment and market positioning.
1 Dec
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) during Monday trading, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The increase in ADRs reflects a broader trend of investor interest in Asian markets, driven by various economic factors and market dynamics. This uptick may indicate a positive sentiment towards Asian equities, potentially benefiting companies like 111, Inc. in the long run. The rise in ADRs suggests a moderately noticeable influence on market sentiment towards Asian equities, including 111, Inc.
16 Sep
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) during Tuesday trading, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The increase in ADRs reflects a broader trend of investor interest in Asian markets, driven by various economic factors and market dynamics. This uptick may indicate a positive sentiment towards Asian equities, potentially benefiting companies like 111, Inc. as they gain visibility and investment in the US market. The rise in ADRs suggests a moderately noticeable influence on market sentiment and investor interest in Asian equities, including 111, Inc.
11 Sep
Asian equities traded in the US, including 111, Inc. Sponsored ADR (YI), saw an upward trend in Thursday trading. The rise in American Depositary Receipts (ADRs) reflects growing investor interest in Asian markets, potentially benefiting companies like 111, Inc. as they gain visibility and access to US capital. Market dynamics suggest a favorable environment for ADRs, which could enhance liquidity and investor sentiment towards Asian firms. The upward trend in ADRs indicates a moderately noticeable influence on market sentiment and potential financial performance for 111, Inc.
5 Sep
Asian equities traded in the US saw a rise in American Depositary Receipts (ADRs) on Friday, with 111, Inc. Sponsored ADR (YI) being among the notable performers. The increase in ADRs reflects a broader trend of investor interest in Asian markets, driven by various economic factors and market dynamics. This uptick may indicate a positive sentiment towards Asian companies listed in the US, potentially benefiting their market performance. The rise in ADRs suggests a moderately noticeable influence on market sentiment and could affect the company's competitive positioning.
20 Jun
111, Inc. (NASDAQ:YI) reported a net loss of CN¥17.6 million for Q1 2025, widening by 28% from the previous year, with a loss per share of CN¥2.04 compared to CN¥1.61 in Q1 2024. Revenue remained flat at CN¥3.53 billion. Despite the losses, revenue is forecasted to grow by 11% annually over the next three years, outpacing the Consumer Retailing industry's 4.9% growth forecast. The company's shares have declined by 2.1% over the past week, and there is one warning sign identified for investors to consider. The widening losses and flat revenue may moderately influence investor sentiment and financial performance.
19 Jun
111, Inc. reported its first quarter 2025 unaudited financial results, with net revenues of RMB3.5 billion (US$486.3 million), remaining flat year-over-year. Operating expenses decreased by 4.8% to RMB195.0 million (US$26.9 million), representing 5.5% of revenues. Income from operations fell to RMB0.1 million (US$0.02 million), while non-GAAP income from operations was RMB4.3 million (US$0.6 million). The company maintained positive operating cash flow of RMB112.6 million (US$15.5 million). CEO Junling Liu highlighted the company's operational profitability amid a challenging macroeconomic environment and emphasized a focus on efficiency and technology investments for future growth. The company's stable revenues and operational profitability indicate moderate resilience, but the decline in income from operations and net loss suggest challenges ahead.
10 Jun
Investors in 111, Inc. Sponsored ADR (YI) have experienced a staggering 87% loss over the past five years. The company's stock has struggled significantly, reflecting broader challenges in its operational performance and market conditions. As a result, many shareholders are facing substantial financial setbacks, raising concerns about the company's future prospects and investor sentiment. The significant loss in stock value indicates potential challenges in financial performance and market sentiment that could moderately influence the company's trajectory.
21 Apr
111, Inc. (YI) reported Q4 2024 total net revenues of RMB3.8 billion, down 6.3% year-over-year, with a gross profit of RMB202.5 million, a decrease of 5.5%. Operating expenses fell by 50.1% to RMB209.8 million, leading to an operating loss of RMB2.3 million, an improvement of 95.8%. The full year 2024 saw revenues of RMB14.4 billion, down 3.7%, but the company achieved its first-ever operational profitability and positive cash flow of RMB263 million. Challenges included macroeconomic uncertainties and a 2.2% drop in China's retail pharmacy sales. Despite these hurdles, the company expanded its digital capabilities and logistics network. Positive operational changes were noted, but a net loss attributable to shareholders of RMB14.8 million highlighted ongoing financial challenges. Achieving operational profitability and positive cash flow indicates significant strategic improvements that could alter the company's trajectory.
21 Mar
111, Inc. reported a loss of CN¥7.54 per share for the full year 2024, a significant improvement compared to a loss of CN¥46.58 per share in FY 2023. The company continues to face challenges but shows signs of reduced losses year-over-year. The reduction in losses indicates some operational improvements, but overall financial performance remains weak.
20 Mar
111, Inc. reported its fourth quarter and fiscal year 2024 financial results, achieving its first-ever annual operating profit and positive operating cash flow. For Q4 2024, net revenues were RMB3.8 billion, a 6.3% decrease year-over-year, while total operating expenses improved by 50.1%. The company reported a loss from operations of RMB7.3 million, a 96.5% improvement from the previous year. For the full year, net revenues were RMB14.4 billion, down 3.7%, but income from operations reached RMB2.1 million, a significant turnaround from a loss of RMB350.1 million in 2023. The company emphasized its focus on operational efficiency and strategic investments in AI and digital technologies to enhance its competitive position in the healthcare market. Achieving its first-ever annual operating profit and positive cash flow indicates a significant turnaround and strategic improvement.
24 Jan
111, Inc. Sponsored ADR (YI) is highlighted as a penny stock to watch in January 2025 due to its recent performance and potential growth opportunities. The company is positioned in the healthcare sector, focusing on innovative solutions that may attract investor interest. Market analysts suggest that YI's strategic initiatives could lead to increased visibility and trading volume, making it a candidate for speculative investment. Investors are advised to monitor developments closely as the new year unfolds. Potential growth opportunities and strategic initiatives may moderately influence the company's market performance.
28 Nov
US Penny Stocks To Watch In November 2024 highlights potential penny stock options in the U.S. market, including Telos Corporation and 111, Inc., among others. The article discusses significant developments and challenges faced by 111, Inc., which could have a profound impact on its future performance and market position.
111, Inc. achieved sustained profitability in Q3 2024 with a 10.5% increase in gross segment profit and a 23.2% reduction in operating expenses. The sustained profitability and operational efficiency improvements in Q3 2024 are expected to significantly impact 111, Inc.'s future performance and market trajectory.
111 reported third quarter 2024 earnings with CN¥0.20 loss per share, revenue down 1.8% from last year, and net loss narrowed by 82%. The significant improvement in financial performance and forecasted revenue growth of 11% p.a. indicate a potential major impact on 111, Inc.'s future trajectory.
111 Inc (YI) reported flat total net revenues of RMB3.6 billion in Q3 2024, but achieved operational profitability with a 10.5% increase in profit to RMB210.6 million. The article highlights improvements in income from operations and cost management, but also mentions challenges in revenue growth and industry competition.
27 Nov
111 Inc. (YI) reported a loss of $2.4 million in Q3 with revenue of $513.1 million. The reported loss and revenue figures may moderately influence the company's financial performance.
111, Inc. (YI), a leading Chinese e-commerce platform for health and wellness products, has delivered explosive revenue growth—nearly 15-fold to $1.97 billion in 2024 since its 2018 U.S. IPO—amid persistent profitability struggles exacerbated by COVID disruptions and competitive pressures. Recent signs of stabilization emerged in 2024, with losses narrowing dramatically (EBT margin to -0.14%), free cash flow turning positive at $34 million, and debt halved, positioning YI as cash-rich despite negative equity. A sharp stock rebound from 2024 lows has ignited momentum, decoupling from past volatility tied to China regulatory crackdowns and macro headwinds.
Operational efficiencies shine through surging revenue per employee (up 1,129% to $1.59 million) and per share (to $229.63), fueling projections of revenue acceleration to $2.75 billion by 2027 (+39% from 2024) alongside breakeven profitability. Yet thin gross margins (5.8%) and zero recent insider activity temper enthusiasm, while Wall Street’s unanimous price targets imply a staggering 4,620% upside from recent levels—pricing in hyper-growth at historically depressed multiples.
This high-risk turnaround embodies China’s e-commerce recovery thesis: a data-driven revival with 1-in-4 odds for moonshot returns, blending robust growth metrics (composite score 7.2/10) against geopolitical risks and execution hurdles. Dive deeper for the full quantitative breakdown.